Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy

Caitlin O. McAtee; Joseph J. Barycki; Melanie A. Simpson

doi:10.1016/b978-0-12-800092-2.00001-0

Cited by 204Proteoglycans and glycosaminoglycans researchHydrogels: synthesis, properties, applicationsProtease and Inhibitor Mechanisms

Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy

Open access

Caitlin O. McAtee, Joseph J. Barycki, Melanie A. Simpson·2014·Advances in Cancer Research

DOI 10.1016/b978-0-12-800092-2.00001-0PMC PMC4445717

Open this paper in CoChat — free account

Abstract

Hyaluronidases are a family of five human enzymes that have been differentially implicated in the progression of many solid tumor types, both clinically and in functional studies. Advances in the past 5 years have clarified many apparent contradictions: (1) by demonstrating that specific hyaluronidases have alternative substrates to hyaluronan (HA) or do not exhibit any enzymatic activity, (2) that high-molecular weight HA polymers elicit signaling effects that are opposite those of the hyaluronidase-digested HA oligomers, and (3) that it is actually the combined overexpression of HA synthesizing enzymes with hyaluronidases that confers tumorigenic potential. This review examines the literature supporting these conclusions and discusses novel mechanisms by which hyaluronidases impact invasive tumor cell processes. In addition, a detailed structural and functional comparison of the hyaluronidases is presented with insights into substrate selectivity and potential for therapeutic targeting. Finally, technological advances in targeting hyaluronidase for tumor imaging and cancer therapy are summarized.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-800092-2.00001-0

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hyaluronidase, γ-Glutamyltranspeptidase, prostate-specific antigen, Trysin, β-galactosidase, Azoreductase, etc. are also used in enzyme-stimulated response smart nano-delivery systems.
“In addition, hyaluronidase, γ-Glutamyltranspeptidase, prostate-specific antigen, Trysin, β-galactosidase, Azoreductase, etc. are also used in enzyme-stimulated response smart nano-delivery systems.157–162”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [158]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis
Tan, J., Wang, X., Su, X., Li, H., Shi, Y., Wang, L., & Ren, G.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022836 · Cited by 72 · see citing works
Retracted
Protein structure prediction on the Web: a case study using the Phyre server
Kelley, L. A., & Sternberg, M. J. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.2 · Cited by 4,154 · see citing works
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A. A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,439 · see citing works
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195 · see citing works
Hyaluronan: its nature, distribution, functions and turnover.
Fraser, J. R. E., Laurent, T. C., & Laurent, U. B. G. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00170.x · Cited by 2,031 · see citing works
Angiogenesis Induced by Degradation Products of Hyaluronic Acid
West, D. C., HAMPSON, I. N., Arnold, F., & Kumar, S. (1985) · Science · doi:10.1126/science.2408340 · Cited by 1,140 · see citing works
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme
Camenisch, T. D., Spicer, A. P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M. L., Calabro, A., Kubalak, S., Klewer, S. E., & McDonald, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10272 · Cited by 901 · see citing works
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties
Itano, N., Sawai, T., Yoshida, M., Lenas, P., Yamada, Y., Imagawa, M., Shinomura, T., Hamaguchi, M., Yoshida, Y., Ohnuki, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25085 · Cited by 901 · see citing works
Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
Webber, J. P., Steadman, R., Mason, M. D., Tabi, Z., & Clayton, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1722 · Cited by 850 · see citing works
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat
Tian, X., Azpurua, J., Hine, C., Vaidya, A. M., Myakishev-Rempel, M., Ablaeva, J., Mao, Z., Nevo, E., Gorbunova, V. A., & Seluanov, A. (2013) · Nature · doi:10.1038/nature12234 · Cited by 786 · see citing works
The six hyaluronidase-like genes in the human and mouse genomes
Csoka, A. B., Frost, G. I., & Stern, R. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00172-x · Cited by 590 · see citing works
Hyaluronan in morphogenesis
Toole, B. P. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0244 · Cited by 571 · see citing works
The structure and function of hyaluronan: An overview
Laurent, T. C., Laurent, U. B. G., & Fraser, J. R. E. (1996) · Immunology and Cell Biology · doi:10.1038/icb.1996.32 · Cited by 506 · see citing works
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Webber, J. P., Spary, L. K., Sanders, A. J., Chowdhury, R., Jiang, W. G., Steadman, R., Wymant, J. M., Jones, A. T., Kynaston, H., Mason, M. D., et al. (2014) · Oncogene · doi:10.1038/onc.2013.560 · Cited by 438 · see citing works
Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery
Jiang, T., Zhang, Z.-H., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 361 · see citing works
The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity
West, D. C., & Kumar, S. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90428-x · Cited by 357 · see citing works
Hyaluronan in morphogenesis
Toole, B. P. (1997) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1997.00171.x · Cited by 325 · see citing works
CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2
Harada, H., & Takahashi, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608358200 · Cited by 321 · see citing works
The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
Yang, C., Cao, M., Liu, H., He, Y., Xu, J., Du, Y., Liu, Y., Wang, W., Cui, L., Hu, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349209 · Cited by 310 · see citing works
Stromal and Epithelial Expression of Tumor Markers Hyaluronic Acid and HYAL1 Hyaluronidase in Prostate Cancer
Lokeshwar, V. B., RUBINOWICZ, D. M., Schroeder, G. L., Forgacs, E., Minna, J. D., Block, N. L., Nadji, M., & Lokeshwar, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008432200 · Cited by 303 · see citing works
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
Kosaki, R., Watanabe, K., & Yamaguchi, Y. (1999) · PubMed · Cited by 303 · see citing works
HYAL2, a Human Gene Expressed in Many Cells, Encodes a Lysosomal Hyaluronidase with a Novel Type of Specificity
Lepperdinger, G., Strobl, B., & Kreil, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22466 · Cited by 300 · see citing works
CD44 Interaction with Tiam1 Promotes Rac1 Signaling and Hyaluronic Acid-mediated Breast Tumor Cell Migration
Bourguignon, L., Zhu, H., Shao, L., & Chen, Y. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1829 · Cited by 284 · see citing works
The role of hyaluronan in tumour neovascularization (review)
Rooney, P., Kumar, S., Ponting, J., & Wang, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600511 · Cited by 271 · see citing works
Host Matrix Modulation by Tumor Exosomes Promotes Motility and Invasiveness
Mu, W., Rana, S., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.13786 · Cited by 248 · see citing works
Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism
Tammi, R., Rilla, K. J., Pienimäki, J.-P., MacCallum, D. K., Hogg, M. G., Luukkonen, M., Hascall, V., & Tammi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103481200 · Cited by 241 · see citing works
A novel PKC-regulated mechanism controls CD44–ezrin association and directional cell motility
Legg, J. W., LEWIS, C. A., Parsons, M., Ng, T., & Isacke, C. M. (2002) · Nature Cell Biology · doi:10.1038/ncb797 · Cited by 238 · see citing works
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.026 · Cited by 223 · see citing works
Structure of Human Hyaluronidase-1, a Hyaluronan Hydrolyzing Enzyme Involved in Tumor Growth and Angiogenesis ,
Chao, K. L., Muthukumar, L., & Herzberg, O. (2007) · Biochemistry · doi:10.1021/bi700382g · Cited by 190 · see citing works
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Vu, B. L., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3 · Cited by 190 · see citing works
HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor
Lokeshwar, V. B., Cerwinka, W. H., Isoyama, T., & Lokeshwar, B. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1022 · Cited by 172 · see citing works
Targeting Hyaluronidase for Cancer Therapy: Antitumor Activity of Sulfated Hyaluronic Acid in Prostate Cancer Cells
Benitez, A., Yates, T. J., López, L. E., Cerwinka, W. H., Bakkar, A., & Lokeshwar, V. B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4610 · Cited by 157 · see citing works
Inhibition of Prostate Tumor Cell Hyaluronan Synthesis Impairs Subcutaneous Growth and Vascularization in Immunocompromised Mice
Simpson, M. A., Wilson, C. M., & McCarthy, J. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64245-9 · Cited by 151 · see citing works
Self-citation
Spontaneous Metastasis of Prostate Cancer Is Promoted by Excess Hyaluronan Synthesis and Processing
Bharadwaj, A. G., Kovar, J. L., Loughman, E., Elowsky, C. G., Oakley, G. G., & Simpson, M. A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080501 · Cited by 141 · see citing works
Self-citation
l-Ascorbic Acid 6-Hexadecanoate, a Potent Hyaluronidase Inhibitor
Botzki, A., Rigden, D. J., Braun, S. A., Nukui, M., Salmen, S., Hoechstetter, J., Bernhardt, G., Dove, S., Jedrzejas, M. J., & Buschauer, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406146200 · Cited by 140 · see citing works
Selective Expression and Functional Characteristics of Three Mammalian Hyaluronan Synthases in Oncogenic Malignant Transformation
Itano, N., Sawai, T., Atsumi, F., Miyaishi, O., Taniguchi, S., Kannagi, R., Hamaguchi, M., & Kimata, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313178200 · Cited by 138 · see citing works
HYAL1 overexpression is correlated with the malignant behavior of human breast cancer
Tan, J., Wang, X., Li, H., Su, X., Wang, L., Liang, R., Zheng, K., & Ren, G. (2010) · International Journal of Cancer · doi:10.1002/ijc.25460 · Cited by 127 · see citing works
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis
Kramer, M. W., Escudero, D. O., Lokeshwar, S. D., Golshani, R., Ekwenna, O., Acosta, K., Merseburger, A. S., Soloway, M. S., & Lokeshwar, V. B. (2010) · Cancer · doi:10.1002/cncr.25565 · Cited by 125 · see citing works
Interaction of low molecular weight hyaluronan with CD44 and toll‐like receptors promotes the actin filament‐associated protein 110‐actin binding and MyD88‐NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion
Bourguignon, L., Wong, G., Earle, C. A., & Xia, W. (2011) · Cytoskeleton · doi:10.1002/cm.20544 · Cited by 124 · see citing works
Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors
Jacobson, A., Rahmanian, M., Rubin, K., & Heldin, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10683 · Cited by 121 · see citing works
Hyaluronan production enhances shedding of plasma membrane-derived microvesicles
Rilla, K. J., Pasonen‐Seppänen, S., Deen, A. J., Koistinen, V., Wojciechowski, S., Oikari, S., Kärnä, R., Bart, G., Törrönen, K., Tammi, R., et al. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.021 · Cited by 119 · see citing works
Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
Posey, J., Soloway, M. S., Eki̇ci̇, S., Sofer, M., Civantos, F., DUNCAN, R. C., & Lokeshwar, V. B. (2003) · PubMed · Cited by 117 · see citing works
Hyaluronidase Expression Induces Prostate Tumor Metastasis in an Orthotopic Mouse Model
Kovar, J. L., Johnson, M. A., Volcheck, W. M., Chen, J., & Simpson, M. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060324 · Cited by 115 · see citing works
Self-citation
Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
Cheng, X., Sato, N., Kohi, S., & Yamaguchi, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080765 · Cited by 112 · see citing works
Quantitative imaging of lymph function
Sharma, R. G., Wang, W. J., Rasmussen, J. C., Joshi, A., Houston, J. P., Adams, K. E., Cameron, A. G., Shi, K., Kwon, S., Mawad, M. E., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01223.2006 · Cited by 109 · see citing works
Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence
Kaneiwa, T., Mizumoto, S., Sugahara, K., & Yamada, S. (2009) · Glycobiology · doi:10.1093/glycob/cwp174 · Cited by 100 · see citing works
Genetic Deletions in Sputum as Diagnostic Markers for Early Detection of Stage I Non–Small Cell Lung Cancer
Li, R., Todd, N. W., Qiu, Q., Fan, T., Zhao, Y., Rodgers, W. H., Fang, H.-B., Katz, R. L., Stass, S. A., & Jiang, F. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1593 · Cited by 98 · see citing works
Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL‐1), CD44v6 and microvessel density for prostate cancer
Eki̇ci̇, S., Cerwinka, W. H., DUNCAN, R. C., Gomez, P., Civantos, F., Soloway, M. S., & Lokeshwar, V. B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20368 · Cited by 95 · see citing works
Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus
Danilkovitch‐Miagkova, A., Duh, F.-M. C., Kuzmin, I., Angeloni, D., Liu, S., Miller, A. D., & Lerman, M. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837136100 · Cited by 94 · see citing works
Indocyanine green encapsulated nanogels for hyaluronidase activatable and selective near infrared imaging of tumors and lymph nodes
Mok, H., Jeong, H., Kim, S.-J., & Chung, B. H. (2012) · Chemical Communications · doi:10.1039/c2cc33555g · Cited by 92 · see citing works
Hyaluronan Stabilizes Focal Adhesions, Filopodia, and the Proliferative Phenotype in Esophageal Squamous Carcinoma Cells
Twarock, S., Tammi, M., Savani, R. C., & Fischer, J. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093146 · Cited by 91 · see citing works
Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association study
Langevin, S. M., Koestler, D. C., Christensen, B. C., Butler, R. A., Wiencke, J. K., Nelson, H. H., Houseman, E. A., Marsit, C. J., & Kelsey, K. T. (2012) · Epigenetics · doi:10.4161/epi.7.3.19134 · Cited by 91 · see citing works
Regulation of Hyaluronidase Activity by Alternative mRNA Splicing
Lokeshwar, V. B., Schroeder, G. L., Carey, R. I., Soloway, M. S., & Iida, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203821200 · Cited by 89 · see citing works
Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells
Sugahara, K. N., Hirata, T., Tanaka, T. T., Ogino, S., Takeda, M., Terasawa, H., Shimada, I., Tamura, J.-I., ten Dam, G. B., Kuppevelt, T. H. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6198 · Cited by 86 · see citing works
Transforming Growth Factor β1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1
Hsu, L., Schultz, L., Hong, Q., Moer, K. V., Heath, J., Li, M.-Y., Lai, F.-J., Lin, S., Lee, M.-H., Lo, C.-P., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806688200 · Cited by 85 · see citing works
Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions
Duterme, C., Mertens-Strijthagen, J., Tammi, M., & Flamion, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044362 · Cited by 77 · see citing works
HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer
Kramer, M. W., Golshani, R., Merseburger, A. S., Knapp, J., García, A., Hennenlotter, J., DUNCAN, R. C., Soloway, M. S., Jordà, M., Kuczyk, M. A., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.057 · Cited by 76 · see citing works
Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer
Aaltomaa, S. H., Lipponen, P., Tammi, R., Tammi, M., Viitanen, J., Kankkunen, J.-P., & Kosma, V. M. (2002) · Urologia Internationalis · doi:10.1159/000066123 · Cited by 75 · see citing works
Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation
Atmuri, V., Martin, D. C., Hemming, R., Gutsol, A. A., Byers, S., Sahebjam, S., Thliveris, J. A., Mort, J. S., Carmona, E., Anderson, J. E., et al. (2008) · Matrix Biology · doi:10.1016/j.matbio.2008.07.006 · Cited by 72 · see citing works
Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells.
Novak, U., Stylli, S. S., Kaye, A. H., & Lepperdinger, G. (1999) · PubMed · Cited by 71 · see citing works
Concurrent Expression of Hyaluronan Biosynthetic and Processing Enzymes Promotes Growth and Vascularization of Prostate Tumors in Mice
Simpson, M. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060032 · Cited by 71 · see citing works
Self-citation
Overexpression of Hyaluronan Synthase-2 Reduces the Tumorigenic Potential of Glioma Cells Lacking Hyaluronidase Activity
Enegd, B., King, J. A. J., Stylli, S. S., Paradiso, L., Kaye, A. H., & Novak, U. (2002) · Neurosurgery · doi:10.1097/00006123-200206000-00023 · Cited by 71 · see citing works
Expression of PH-20 in Normal and Neoplastic Breast Tissue
Beech, D. J., Madan, A. K., & Deng, N. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6351 · Cited by 69 · see citing works
Hyaluronidase Activity of Human Hyal1 Requires Active Site Acidic and Tyrosine Residues
Zhang, L., Bharadwaj, A. G., Casper, A., Barkley, J., Barycki, J. J., & Simpson, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900210200 · Cited by 68 · see citing works
Self-citation
Role of Virus Receptor Hyal2 in Oncogenic Transformation of Rodent Fibroblasts by Sheep Betaretrovirus Env Proteins
Liu, S., Duh, F.-M. C., Lerman, M. I., & Miller, A. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.5.2850-2858.2003 · Cited by 68 · see citing works
Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis
Bharadwaj, A. G., Rector, K., & Simpson, M. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702964200 · Cited by 66 · see citing works
Self-citation
Involvement of hyaluronidases in colorectal cancer
Bouga, H., Tsouros, I., Bounias, D., Kyriakopoulou, D., Stavropoulos, M., Papageorgakopoulou, N., Theocharis, D. A., & Vynios, D. H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-499 · Cited by 66 · see citing works
Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma
Nykopp, T. K., Rilla, K. J., Tammi, M., Tammi, R., Sironen, R. K., Hämäläinen, K. M., Kosma, V., Heinonen, S. T., & Anttila, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-512 · Cited by 65 · see citing works
Hyaluronidases Have Strong Hydrolytic Activity toward Chondroitin 4-Sulfate Comparable to that for Hyaluronan
Honda, T., Kaneiwa, T., Mizumoto, S., Sugahara, K., & Yamada, S. (2012) · Biomolecules · doi:10.3390/biom2040549 · Cited by 64 · see citing works
HYAL1-v1, An Alternatively Spliced Variant of HYAL1 Hyaluronidase: A Negative Regulator of Bladder Cancer
Lokeshwar, V. B., Estrella, V. C., López, L. E., Kramer, M. W., Gomez, P., Soloway, M. S., & Lokeshwar, B. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1121 · Cited by 62 · see citing works
Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells
Hemming, R., Martin, D. C., Slominski, E., Nagy, J. I., Halayko, A. J., Pind, S., & Triggs‐Raine, B. L. (2008) · Glycobiology · doi:10.1093/glycob/cwn006 · Cited by 62 · see citing works
Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system
Chen, S.-T., Chuang, J., Wang, J. P., Tsai, M., Li, H., & Chang, N. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.036 · Cited by 61 · see citing works
Hyaluronidase gene profiling and role of HYAL‐1 overexpression in an orthotopic model of prostate cancer
Patel, S. K., Turner, P. R., Stubberfield, C. R., Barry, E., Rohlff, C., Stamps, A. C., Tyson, K. L., Terrett, J., Box, G., Eccles, S. A., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1638 · Cited by 60 · see citing works
Magnetic Resonance Imaging Visualization of Hyaluronidase in Ovarian Carcinoma
Shiftan, L., Israely, T., Cohen, M., Frydman, V., Dafni, H., Stern, R., & Neeman, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3947 · Cited by 59 · see citing works
Expression of Hyaluronan Synthases (HAS1–3) and Hyaluronidases (HYAL1–2) in Serous Ovarian Carcinomas: Inverse Correlation between HYAL1 and Hyaluronan Content
Nykopp, T. K., Rilla, K. J., Sironen, R. K., Tammi, M., Tammi, R., Hämäläinen, K. M., Heikkinen, A. M., Komulainen, M. H., Kosma, V., & Anttila, M. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-143 · Cited by 58 · see citing works
Hyaluronated nanoparticles with pH- and enzyme-responsive drug release properties
Kim, S. W., Oh, K. T., Youn, Y. S., & Lee, E. S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.017 · Cited by 57 · see citing works
PH-20
Godin, D. A., Fitzpatrick, P. C., Scandurro, A. B., Belafsky, P. C., Woodworth, B. A., Amedee, R. G., Beech, D. J., & Beckman, B. S. (2000) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.126.3.402 · Cited by 55 · see citing works
Molecular characterization of kidney cancer
Chi, A. S., Shirodkar, S. P., Escudero, D. O., Ekwenna, O., Yates, T. J., Ayyathurai, R., Garcia-Roig, M. L., Gahan, J. C., Manoharan, M., Bird, V. G., et al. (2011) · Cancer · doi:10.1002/cncr.26520 · Cited by 55 · see citing works
Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase
Andre, B., Duterme, C., Moer, K. V., Mertens-Strijthagen, J., Jadot, M., & Flamion, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.125 · Cited by 54 · see citing works
Inhibition of Hyaluronidase by Fully O-Sulfonated Glycosaminoglycans
Toida, T., Ogita, Y., Suzuki, A., Toyoda, H., & Imanari, T. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1395 · Cited by 53 · see citing works
Association of hyaluronidase and breast adenocarcinoma invasiveness.
Madan, A. K., Yu, K., Dhurandhar, N. R., Cullinane, C. M., Pang, Y. K., & Beech, D. J. (1999) · Oncology Reports · doi:10.3892/or.6.3.607 · Cited by 52 · see citing works
Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer
Urakawa, H., Nishida, Y., Knudson, W., Knudson, C. B., Arai, E., Kozawa, E., Futamura, N., Wasa, J., & Ishiguro, N. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21557 · Cited by 52 · see citing works
Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases
Isoyama, T., Thwaites, D., Selzer, M. G., Carey, R. I., Barbucci, R., & Lokeshwar, V. B. (2005) · Glycobiology · doi:10.1093/glycob/cwj036 · Cited by 52 · see citing works
Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase
Chang, J.-Y., He, R., Lin, H., Hsu, L., Lai, F., Hong, Q., Chen, S.-J., & Chang, N. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009351 · Cited by 51 · see citing works
Hyaluronic Acid and HYAL-1 in Prostate Biopsy Specimens: Predictors of Biochemical Recurrence
Gomez, C. S., Gomez, P., Knapp, J., Jordà, M., Soloway, M. S., & Lokeshwar, V. B. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.06.070 · Cited by 47 · see citing works
Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2
Vigdorovich, V. I., Strong, R. K., & Miller, A. D. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.79-86.2005 · Cited by 47 · see citing works
Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors +
Hofinger, E. S. A., Spickenreither, M., Oschmann, J., Bernhardt, G., Rudolph, R., & Buschauer, A. (2007) · Glycobiology · doi:10.1093/glycob/cwm003 · Cited by 45 · see citing works
Subcellular Trafficking and Activity of Hyal‐1 and Its Processed Forms in Murine Macrophages
Emeline, P., Gilis, F., Dogné, S., Flamion, B., Jadot, M., & Boonen, M. (2014) · Traffic · doi:10.1111/tra.12162 · Cited by 43 · see citing works
Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts
Chang, N. (2002) · BMC Cell Biology · doi:10.1186/1471-2121-3-8 · Cited by 43 · see citing works
Inverse expression of hyaluronidase 2 and hyaluronan synthases 1–3 is associated with reduced hyaluronan content in malignant cutaneous melanoma
Siiskonen, H., Poukka, M., Tyynelä-Korhonen, K., Sironen, R. K., & Pasonen‐Seppänen, S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-181 · Cited by 42 · see citing works
Expression of HYAL1 and Survivin RNA as Diagnostic Molecular Markers for Bladder Cancer
Eissa, S., Swellam, M. M., Shehata, H. H., El‐Khouly, I. M., El-Zayat, T. M., & El-Ahmady, O. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.10.024 · Cited by 41 · see citing works
Stimulation of TLR4 by LMW-HA Induces Metastasis in Human Papillary Thyroid Carcinoma through CXCR7
Dang, S., Peng, Y., Ye, L., Wang, Y., Qian, Z., Chen, Y., Wang, X., Lin, Y., Zhang, X., Sun, X., et al. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/712561 · Cited by 39 · see citing works
Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking
McAtee, C. O., Berkebile, A. R., Elowsky, C. G., Fangman, T., Barycki, J. J., Wahl, J. K., Khalimonchuk, O., Naslavsky, N., Caplan, S., & Simpson, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647446 · Cited by 36 · see citing works
Self-citation
Identification of Amino Acid Residues Required for the Substrate Specificity of Human and Mouse Chondroitin Sulfate Hydrolase (Conventional Hyaluronidase-4)
Kaneiwa, T., Miyazaki, A., Kogawa, R., Mizumoto, S., Sugahara, K., & Yamada, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.360693 · Cited by 36 · see citing works
Hyaluronan : structure, metabolism, biological activities, therapeutic applications
Balazs, E. A., & Hascall, V. (2005) · Medical Entomology and Zoology · Cited by 35 · see citing works
Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients
Li, Y., Wang, D., Wang, L., Yu, J., Dan-hua, D., Chen, Y., Gao, P., Wang, D.-M., Yu, J. M., Zhang, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057168 · Cited by 35 · see citing works
Cancer-associated splicing variants of the CDCA1 and MSMB genes expressed in cancer cell lines and surgically resected gastric cancer tissues
Ohnuma, S., Miura, K., Horii, A., Fujibuchi, W., Kaneko, N., Gotoh, O., Nagasaki, H., Mizoi, T., Tsukamoto, N., Kobayashi, T., et al. (2008) · Surgery · doi:10.1016/j.surg.2008.08.010 · Cited by 34 · see citing works
Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer
Yoffou, P. H., Edjekouane, L., Meunier, L., Tremblay, A., Provencher, D. M., Mes‐Masson, A., & Carmona, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020705 · Cited by 33 · see citing works
bFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells
Berdiaki, A., Nikitovic, D., Tsatsakis, A. M., Katonis, P., Karamanos, N. K., & Tzanakakis, G. N. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.013 · Cited by 32 · see citing works
Size-dependent regulation of Snail2 by hyaluronan: Its role in cellular invasion
Craig, E. A., Parker, P., & Camenisch, T. D. (2009) · Glycobiology · doi:10.1093/glycob/cwp064 · Cited by 28 · see citing works
Research Letter: New Potent Indole Derivatives as Hyaluronidase Inhibitors
Ölgen, S., Kaeßler, A., Nebioğlu, D., & Jose, J. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00590.x · Cited by 27 · see citing works
Increased hyaluronidase expression in more aggressive prostate adenocarcinoma.
Madan, A. K., Pang, Y. K., Wilkiemeyer, M. B., Yu, D. C., & Beech, D. J. (1999) · Oncology Reports · doi:10.3892/or.6.6.1431 · Cited by 26 · see citing works
Molecular Risk Assessment for Breast Cancer Development in Patients with Ductal Hyperplasias
Poola, I., Abraham, J., Marshalleck, J. J., Yue, Q., Lokeshwar, V. B., Bonney, G. E., & DeWitty, R. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4053 · Cited by 26 · see citing works
Autodisplay of catalytically active human hyaluronidase hPH-20 and testing of enzyme inhibitors
Kaeßler, A., Ölgen, S., & Jose, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.11.004 · Cited by 24 · see citing works
Hyaluronidases and their inhibitors in the serum of colorectal carcinoma patients
Kolliopoulos, C., Bounias, D., Bouga, H., Kyriakopoulou, D., Stavropoulos, M., & Vynios, D. H. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.05.037 · Cited by 23 · see citing works
Urinary retinoic acid receptor-β2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer
Eissa, S., Zohny, S. F., Shehata, H. H., Hegazy, M. G. A., Salem, A. M. H., & Esmat, M. E. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.01.010 · Cited by 21 · see citing works
Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane
Harigaya, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1114 · Cited by 21 · see citing works
Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: An in vitro and in vivo study
Udabage, L., Brownlee, G. R., Stern, R., & Brown, T. J. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000038292.71098.35 · Cited by 21 · see citing works
Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent
Shiftan, L., & Neeman, M. (2006) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.96 · Cited by 21 · see citing works
FRET Based Ratio-Metric Sensing of Hyaluronidase in Synthetic Urine as a Biomarker for Bladder and Prostate Cancer
Chib, R., Raut, S., Fudala, R., Chang, A., Mummert, M. E., Rich, R., Gryczynski, Z. K., & Gryczyński, I. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/13892010113149990222 · Cited by 20 · see citing works
Molecular mechanisms and imaging of lymphatic metastasis
Proulx, S. T., & Detmar, M. J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.009 · Cited by 20 · see citing works
Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer
Eissa, S., Shehata, H. H., Mansour, A., Esmat, M. E., & El-Ahmady, O. (2012) · Medical Oncology · doi:10.1007/s12032-012-0295-8 · Cited by 19 · see citing works
Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung
de Sá, V. K., Olivieri, E. H. R., Parra, E. R., Ab’Saber, A. M., Takagaki, T. Y., Soares, F. A., Carraro, D. M., Carvalho, L., & Capelozzi, V. L. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.06.010 · Cited by 18 · see citing works
Hyaluronan suppresses prostate tumor cell proliferation through diminished expression of N-cadherin and aberrant growth factor receptor signaling
Bharadwaj, A. G., Goodrich, N. P., McAtee, C. O., Haferbier, K. L., Oakley, G. G., Wahl, J. K., & Simpson, M. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.026 · Cited by 17 · see citing works
Self-citation
Detection of hyaluronidase activity using fluorescein labeled hyaluronic acid and Fluorescence Correlation Spectroscopy
Rich, R. M., Mummert, M. E., Földes‐Papp, Z., Gryczynski, Z. K., Borejdo, J., Gryczyński, I., & Fudala, R. (2012) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2012.07.007 · Cited by 16 · see citing works
Amino acid residues that are important for Hyal2 function as a receptor for jaagsiekte sheep retrovirus
Duh, F.-M. C., Dirks, C., Lerman, M. I., & Miller, A. D. (2005) · Retrovirology · doi:10.1186/1742-4690-2-59 · Cited by 13 · see citing works
Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis
Tzellos, T., Kyrgidis, Α., Vahtsevanos, K., Triaridis, S., Printza, A., Klagas, I., Zvintzou, E., Κritis, A., Karakiulakis, G., & Papakonstantinou, E. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03851.x · Cited by 11 · see citing works
Designed Human Serum Hyaluronidase 1 Variant, HYAL1ΔL, Exhibits Activity up to pH 5.9
Reitinger, S., Müllegger, J., Greiderer‐Kleinlercher, B., Nielsen, J. E., & Lepperdinger, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.004358 · Cited by 10 · see citing works
Role of the extracellular matrix in variations of invasive pathways in lung cancers
de Sá, V. K., Carvalho, L., Gomes, A., Alarcão, A., Silva, M. R., Couceiro, P., de Sousa, V. M. L., Soares, F. A., & Capelozzi, V. L. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20122263 · Cited by 10 · see citing works
Investigation of Aminomethyl Indole Derivatives as Hyaluronidase Inhibitors
Ölgen, S., Kaeßler, A., Kılıç-Kurt, Z., & Jose, J. (2010) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2010-7-805 · Cited by 6 · see citing works
Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis
de Sá, V. K., Canavez, F., da Silva, I. A., Srougi, M., & Leite, K. R. M. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.04.013 · Cited by 6 · see citing works
Analysis of HYAL3 Gene Mutations in Chinese Lung Squamous Cell Carcinoma Patients
Zhang, R., Zhu, J.-H., Fan, J., & Ji, X. (2013) · Tumori Journal · doi:10.1177/030089161309900118 · Cited by 5 · see citing works
Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer
Moog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2

Flagged first, then by citations

4 of the 127 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Godin DA Fitzpatrick PC Scandurro AB Belafsky PC Woodworth BA Amedee RG 2000 PH20: a novel tumor marker for laryngeal cancer Arch Otolaryngol Head Neck Surg 126 402 404 10722016

Sorted by citations

Role of Extracellular Matrix in Development and Cancer Progression
Walker, C., Mojares, E., & Hernández, A. E. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103028 · Cited by 1,103 · see citing works
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073 · see citing works
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages
Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212200 · Cited by 556 · see citing works
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00697 · Cited by 470 · see citing works
Hyaluronan biology: A complex balancing act of structure, function, location and context
Garantziotis, S., & Savani, R. C. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.02.002 · Cited by 390 · see citing works
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 390 · see citing works
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A. G., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 372 · see citing works
Graphene‐Based Smart Platforms for Combined Cancer Therapy
Gu, Z., Zhu, S., Yan, L., Zhao, F., & Zhao, Y. (2018) · Advanced Materials · doi:10.1002/adma.201800662 · Cited by 334 · see citing works
Hyaluronic Acid–Based Activatable Nanomaterials for Stimuli‐Responsive Imaging and Therapeutics: Beyond CD44‐Mediated Drug Delivery
Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 320 · see citing works
Hyaluronan as a therapeutic target in human diseases
Liang, J., Jiang, D., & Noble, P. W. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.017 · Cited by 239 · see citing works
Tumor microenvironment responsive drug delivery systems
He, Q., Chen, J., Yan, J., Cai, S., Xiong, H., Liu, Y., Peng, D., Mo, M., & Liu, Z. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.08.003 · Cited by 222 · see citing works
Transposable Elements in Human Cancer: Causes and Consequences of Deregulation
Anwar, S. L., Wulaningsih, W., & Lehmann, U. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050974 · Cited by 192 · see citing works
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 194 · see citing works
Hyaluronan – A Functional and Structural Sweet Spot in the Tissue Microenvironment
Monslow, J., Govindaraju, P. K., & PurÃ©, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00231 · Cited by 182 · see citing works
Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
Kaushik, N., Borkar, S. B., Nandanwar, S., Panda, P. K., Choi, E. H., & Kaushik, N. K. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01364-2 · Cited by 189 · see citing works
Hyaluronic Acid: Incorporating the Bio into the Material
Wolf, K. J., & Kumar, S. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01268 · Cited by 178 · see citing works
Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations
Pawłowska, E., Szczepańska, J., & Błasiak, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7286737 · Cited by 174 · see citing works
Physical biology of the cancer cell glycocalyx
Kuo, J. C., Gandhi, J. G., Zia, R. N., & Paszek, M. J. (2018) · Nature Physics · doi:10.1038/s41567-018-0186-9 · Cited by 160 · see citing works
Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment
Liu, M., Tölg, C., & Turley, E. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00947 · Cited by 158 · see citing works
Nanogels for intracellular delivery of biotherapeutics
Li, D., van Nostrum, C. F., Mastrobattista, E., Vermonden, T., & Hennink, W. E. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.020 · Cited by 161 · see citing works
Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery
Dolor, A., & Szoka, F. C. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00319 · Cited by 141 · see citing works
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment
Marozzi, M., Parnigoni, A., Negri, A., Viola, M., Vigetti, D., Passi, A. G., Karousou, E. G., & Rizzi, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158102 · Cited by 136 · see citing works
Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
McCarthy, J. B., El‐Ashry, D., & Turley, E. A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00048 · Cited by 128 · see citing works
How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?
Cong, V. T., Houng, J. L., Kavallaris, M., Chen, X., Tilley, R. D., & Gooding, J. J. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00707f · Cited by 124 · see citing works
Oncolytic viruses: overcoming translational challenges
Martínez‐Quintanilla, J., Seah, I. Y. J., Chua, M. M. J., & Shah, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122287 · Cited by 119 · see citing works
Responsive crosslinked polymer nanogels for imaging and therapeutics delivery
Ekkelenkamp, A. E., Elzes, M. R., Engbersen, J. F. J., & Paulusse, J. M. J. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02239e · Cited by 119 · see citing works
Towards extracellular matrix normalization for improved treatment of solid tumors
Abyaneh, H. S., Regenold, M., McKee, T. D., Allen, C. J., & Gauthier, M. A. (2020) · Theranostics · doi:10.7150/thno.39995 · Cited by 117 · see citing works
Natural Ingredient-Based Polymeric Nanoparticles for Cancer Treatment
Wong, K. H., Lü, A., Chen, X., & Yang, Z. (2020) · Molecules · doi:10.3390/molecules25163620 · Cited by 115 · see citing works
Cancer Microenvironment and Inflammation: Role of Hyaluronan
Nikitovic, D., Tzardi, M. N., Berdiaki, A., Tsatsakis, A. M., & Tzanakakis, G. N. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00169 · Cited by 111 · see citing works
Extracellular matrix proteomics in schizophrenia and Alzheimer’s disease
Sethi, M. K., & Zaia, J. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9900-6 · Cited by 109 · see citing works
Hyaluronan as tunable drug delivery system
Passi, A. G., & Vigetti, D. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.006 · Cited by 112 · see citing works
Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents
He, H., Sun, L., Ye, J., Liu, E., Chen, S., Liang, Q., Shin, M. C., & Yang, V. C.-M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.040 · Cited by 111 · see citing works
Cell Energy Metabolism and Hyaluronan Synthesis
Caon, I., Parnigoni, A., Viola, M., Karousou, E. G., Passi, A. G., & Vigetti, D. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420929772 · Cited by 109 · see citing works
Charge‐Reversible Nanoparticles: Advanced Delivery Systems for Therapy and Diagnosis
Veider, F., Armengol, E. S., & Bernkop‐Schnürch, A. (2023) · Small · doi:10.1002/smll.202304713 · Cited by 108 · see citing works
Activatable Phototheranostic Materials for Imaging-Guided Cancer Therapy
Cheng, P., & Pu, K. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15064 · Cited by 107 · see citing works
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 109 · see citing works
Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review
Michalczyk, M., Humeniuk, E., Adamczuk, G., & Korga-Plewko, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010103 · Cited by 106 · see citing works
A Novel Multimodal NIR-II Nanoprobe for the Detection of Metastatic Lymph Nodes and Targeting Chemo-Photothermal Therapy in Oral Squamous Cell Carcinoma
Wang, Y., Zhang, W., Sun, P., Cai, Y., Xu, W., Fan, Q., Hu, Q., & Han, W. (2019) · Theranostics · doi:10.7150/thno.30268 · Cited by 97 · see citing works
Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance
Price, Z. K., Lokman, N. A., & Ricciardelli, C. (2018) · Cancers · doi:10.3390/cancers10120482 · Cited by 98 · see citing works
Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities
Lin, G., Revia, R. A., & Zhang, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202007096 · Cited by 97 · see citing works
Characterization of the tumor microenvironment and tumor–stroma interaction by non-invasive preclinical imaging
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93 · see citing works
A Trickster in Disguise: Hyaluronan’s Ambivalent Roles in the Matrix
Bohaumilitzky, L., Huber, A., Stork, E. M., Wengert, S., Woelfl, F., & Boehm, H. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00242 · Cited by 91 · see citing works
Glycosylation and Cancer: Moving Glycomics to the Forefront
Drake, R. R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.12.002 · Cited by 87 · see citing works
The DNMT1-PAS1-PH20 axis drives breast cancer growth and metastasis
Fu, Y., Zhang, X., Liu, X., Wang, P., Chu, W., Zhao, W., Wang, Y., Zhou, G., Yu, Y., & Zhang, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00896-1 · Cited by 88 · see citing works
CD147
Grass, G. D., Dai, L., Qin, Z., Parsons, C. H., & Toole, B. P. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-800092-2.00013-7 · Cited by 82 · see citing works
Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview
Kapalatiya, H., Madav, Y., Tambe, V. S., & Wairkar, S. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01020-6 · Cited by 81 · see citing works
Carcinoma Cell Hyaluronan as a “Portable” Cancerized Prometastatic Microenvironment
Turley, E. A., Wood, D. K., & McCarthy, J. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3114 · Cited by 77 · see citing works
Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases
Rao, N. V., Rho, J. G., Um, W., Ek, P. K., Nguyen, V. Q., Oh, B. H., Kim, W., & Park, J. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100931 · Cited by 78 · see citing works
pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy
Lai, H., Ding, X., Ye, J., Deng, J., & Cui, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111455 · Cited by 76 · see citing works
Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets
Lu, J., Zhao, Z., Pan, L., Wu, H. C., Wang, S., Tong, X., & Wu, S. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00299-y · Cited by 82 · see citing works
Hyaluronan in adipogenesis, adipose tissue physiology and systemic metabolism
Zhu, Y., Kruglikov, I. L., Akgul, Y., & Scherer, P. E. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.012 · Cited by 75 · see citing works
Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling
McAtee, C. O., Booth, C. S., Elowsky, C. G., Zhao, L. Q., Payne, J., Fangman, T., Caplan, S., Henry, M. D., & Simpson, M. A. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.05.002 · Cited by 72 · see citing works
Self-citation
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
Morera, D. S., Hennig, M., Talukder, A. M., Lokeshwar, S. D., Wang, J., Garcia-Roig, M. L., Ortiz, N., Yates, T. J., López, L. E., Kallifatidis, G., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.318 · Cited by 71 · see citing works
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis
Sugahara, K. N., Scodeller, P., Braun, G. B., de Mendoza, T. H., Yamazaki, C. M., Kluger, M. D., Kitayama, J., Alvarez, E. A., Howell, S. B., Teesalu, T., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.009 · Cited by 70 · see citing works
Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells
Mesquita, A. P. D. S., Lopes, S. D. A., Filho, P. C. A. P., Nader, H. B., & Lopes, C. C. (2017) · APOPTOSIS · doi:10.1007/s10495-017-1392-0 · Cited by 67 · see citing works
Strategies for Glycoengineering Therapeutic Proteins
Dammen-Brower, K., Epler, P., Zhu, S., Bernstein, Z. J., Stabach, P., Braddock, D., Spangler, J. B., & Yarema, K. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.863118 · Cited by 54 · see citing works
Targets of tumor microenvironment for potential drug development
Zhang, L., Wang, Z., Liu, K., Liu, Y., Wang, S., Jiang, W., Lu, F., & Dang, Y. (2024) · MedComm – Oncology · doi:10.1002/mog2.68 · Cited by 63 · see citing works
Tumor microenvironment and nanotherapeutics: intruding the tumor fort
Kiran, A. V. V. V. R., Kumari, G. K., Krishnamurthy, P. T., & Khaydarov, R. R. (2021) · Biomaterials Science · doi:10.1039/d1bm01127h · Cited by 60 · see citing works
Co-localization and crosstalk between CD44 and RHAMM depend on hyaluronan presentation
Carvalho, A. M., da Costa, D. S., Paulo, P. M. R., Reis, R. L., & Pashkuleva, I. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.10.024 · Cited by 57 · see citing works
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 57 · see citing works
Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?
Machado, V., Morais, M., & Medeiros, R. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102092 · Cited by 53 · see citing works
Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors
Cheng, X., Li, H., Ge, X., Chen, L., Liu, Y., Mao, W., Zhao, B., & Yuan, W. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.576420 · Cited by 50 · see citing works
Advances and Challenges of Stimuli-Responsive Nucleic Acids Delivery System in Gene Therapy
Lin, M., & Qi, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051450 · Cited by 51 · see citing works
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer Therapy
Berdiaki, A., Neagu, M. T., Giatagana, E.-M., Николаевич, К. А., Tsatsakis, A. M., Tzanakakis, G. N., & Nikitovic, D. (2021) · Biomolecules · doi:10.3390/biom11030395 · Cited by 50 · see citing works
Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure–activity relationship
Gębalski, J., Graczyk, F., & Załuski, D. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2061966 · Cited by 49 · see citing works
Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems
Sethuraman, V., Janakiraman, K., Krishnaswami, V., & Kandasamy, R. (2021) · Current Drug Targets · doi:10.2174/1389450122999210128180058 · Cited by 47 · see citing works
Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity
Fatima, K., Masood, N., Wani, Z. A., Meena, A., & Luqman, S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.003 · Cited by 46 · see citing works
Covalent conjugation and non-covalent complexation strategies for intracellular delivery of proteins using cell-penetrating peptides
Behzadipour, Y., & Hemmati, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116910 · Cited by 44 · see citing works
Comparative study of GC‐MS characterization, antioxidant activity and hyaluronidase inhibition of different species of Lavandula and Thymus essential oils
Carrasco, A., Pérez‐Ruiz, T., Tudela, J., & Miguel, M. G. (2015) · Flavour and Fragrance Journal · doi:10.1002/ffj.3283 · Cited by 44 · see citing works
Insights into the source, mechanism and biotechnological applications of hyaluronidases
Zhang, Y.-S., Gong, J., Yao, Z.-Y., Jiang, J., Su, C., Li, H., Kang, C.-L., Liu, L., Xu, Z., & Shi, J. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.108018 · Cited by 43 · see citing works
Quercetin liposomes conjugated with hyaluronidase: An efficient drug delivery system to block pancreatic cancer
Sun, G., Wu, Y., Li, J., Yang, M., Xu, H., Li, Y., Tong, P., Shao, R., Liu, Y., & Kong, X. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113642 · Cited by 44 · see citing works
Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice
Zhang, B., Jiang, T., She, X., Shen, S., Wang, S., Deng, J., Shi, W., Mei, H., Hu, Y., Pang, Z., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.015 · Cited by 43 · see citing works
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Nichols, J. W., Sakurai, Y., Harashima, H., & Bae, Y. H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.003 · Cited by 43 · see citing works
Targeting the lysyl oxidases in tumour desmoplasia
Chitty, J. L., Setargew, Y. F. I., & Cox, T. R. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190098 · Cited by 43 · see citing works
Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment
Peng, Y., Bariwal, J. B., Kumar, V., Tan, C., & Mahato, R. I. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900136 · Cited by 43 · see citing works
Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed
Hsu, L., Hong, Q., Chen, S.-T., Kuo, H.-L., Schultz, L., Heath, J., Lin, S., Lee, M.-H., Li, D.-Z., Li, Z.-L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13268 · Cited by 40 · see citing works
Hyaluronan in the experimental injury of the cartilage: biochemical action and protective effects
Avenoso, A., D’Ascola, A., Scuruchi, M., Mandraffino, G., Calatroni, A., Saitta, A., Campo, S., & Campo, G. M. (2017) · Inflammation Research · doi:10.1007/s00011-017-1084-9 · Cited by 40 · see citing works
Enzyme-Assisted Photodynamic Therapy Based on Nanomaterials
Du, B., & Tung, C. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00968 · Cited by 39 · see citing works
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
Dissanayake, R. K., Towner, R. A., & Ahmed, M. (2023) · Cancers · doi:10.3390/cancers15112906 · Cited by 37 · see citing works
Exosomes as a storehouse of tissue remodeling proteases and mediators of cancer progression
Das, A., Mohan, V., Krishnaswamy, V. R., Solomonov, I., & Sagi, I. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09813-5 · Cited by 37 · see citing works
Hyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking
McAtee, C. O., Berkebile, A. R., Elowsky, C. G., Fangman, T., Barycki, J. J., Wahl, J. K., Khalimonchuk, O., Naslavsky, N., Caplan, S., & Simpson, M. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.647446 · Cited by 36 · see citing works
Self-citation
Recent advances in nanocarriers-based drug delivery for cancer therapeutics: A review
Yadav, P., Jain, J., & Sherje, A. P. (2021) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2021.104970 · Cited by 36 · see citing works
Equilibrium Modeling of the Mechanics and Structure of the Cancer Glycocalyx
Gandhi, J. G., Koch, D. L., & Paszek, M. J. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2018.12.023 · Cited by 35 · see citing works
Evolution of high-molecular-mass hyaluronic acid is associated with subterranean lifestyle
Zhao, Y., Zheng, Z., Zhang, Z., Xu, Y., Hillpot, E., Lin, Y. S., Zakusilo, F. T., Lu, J. Y., Ablaeva, J., Biashad, S. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43623-2 · Cited by 34 · see citing works
Sporothriolide-Related Compounds from the Fungus Hypoxylon monticulosum CLL-205 Isolated from a Sphaerocladina Sponge from the Tahiti Coast
Leman-Loubière, C., Goff, G. L., Retailleau, P., Debitus, C., & Ouazzani, J. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00714 · Cited by 33 · see citing works
Receptor for hyaluronic acid- mediated motility (RHAMM) regulates HT1080 fibrosarcoma cell proliferation via a β-catenin/c-myc signaling axis
Kouvidi, K., Berdiaki, A., Tzardi, M. N., Karousou, E. G., Passi, A. G., Nikitovic, D., & Tzanakakis, G. N. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.019 · Cited by 32 · see citing works
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis
Perkins, R. S., Murray, G., Suthon, S., Davis, L., Perkins, N. B., Fletcher, L. B., Bozzi, A., Schreiber, S. L., Lin, J., Laxton, S. J., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1670 · Cited by 30 · see citing works
Oil-in-microgel strategy for enzymatic-triggered release of hydrophobic drugs
Busatto, C. A., Labie, H., Lapeyre, V., Auzély‐Velty, R., Perro, A., Casís, N., Luna, J. A., Estenoz, D. A., & Ravaine, V. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.01.029 · Cited by 31 · see citing works
A guide to hyaluronan and related enzymes in breast cancer: biological significance and diagnostic value
Velesiotis, C., Vasileiou, S., & Vynios, D. H. (2019) · FEBS Journal · doi:10.1111/febs.14860 · Cited by 31 · see citing works
Cirsimaritin, a lung squamous carcinoma cells (NCIH-520) proliferation inhibitor
Pathak, G., Singh, S., Kumari, P., Raza, W., Hussain, Y., & Meena, A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763198 · Cited by 32 · see citing works
Tumor Microenvironment-Responsive Nanomaterials as Targeted Delivery Carriers for Photodynamic Anticancer Therapy
Liu, H., Jiwen, Y., Guo, H., Cai, X., Jiang, Y., Lin, M., Jiang, X., Leung, W., & Xu, C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00758 · Cited by 31 · see citing works
Halting hyaluronidase activity with hyaluronan-based nanohydrogels: development of versatile injectable formulations
Montanari, E., Zoratto, N., Mosca, L., Cervoni, L., Lallana, E., Angelini, R., Matassa, R., Coviello, T., Meo, C. D., & Matricardi, P. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.06.004 · Cited by 30 · see citing works
The CD147‐HYALURONAN Axis in Cancer
Toole, B. P. (2019) · The Anatomical Record · doi:10.1002/ar.24147 · Cited by 30 · see citing works
Nanomedicines with high drug availability and drug sensitivity overcome hypoxia-associated drug resistance
Liu, Y., Dong, W., Ma, Y., Dou, J., Jiang, W., Wang, L., Wang, Q., Li, M., Wang, Y., & Li, M. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122023 · Cited by 30 · see citing works
Cirsilineol inhibits proliferation of lung squamous cell carcinoma by inducing ROS mediated apoptosis
Pathak, G., Singh, S., Kumari, P., Hussain, Y., Raza, W., Luqman, S., & Meena, A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111550 · Cited by 28 · see citing works
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer
Jordan, A. R., Lokeshwar, S. D., López, L. E., Hennig, M. J. P., Chipollini, J. J., Yates, T. J., Hupe, M. C., Merseburger, A. S., Shiedlin, A., Cerwinka, W. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10529 · Cited by 29 · see citing works
Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation
Kohi, S., Sato, N., Koga, A., Hirata, K., Harunari, E., & Igarashi, Y. (2016) · Journal of Oncology · doi:10.1155/2016/9063087 · Cited by 29 · see citing works
Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer Immunotherapy
Rodella, G., Véronique Préat, A., Gallez, B., & Malfanti, A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113784 · Cited by 28 · see citing works
Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy
Fu, J., Wu, Z., Liu, J., & Wu, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110588 · Cited by 28 · see citing works
The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems
Foglietta, F., Serpe, L., & Canaparo, R. (2021) · Cells · doi:10.3390/cells10123295 · Cited by 27 · see citing works

Authors: McAtee, C. O., Barycki, J. J., & Simpson, M. A.
Affiliations: University of Nebraska–Lincoln (US)
Corresponding author: Melanie A. Simpson
ORCID: Joseph J. Barycki
Melanie A. Simpson
Venue: Advances in Cancer Research
Publisher: Elsevier
Published: 2014
Volume: 123
Pages: 1-34
ISSN: 0065-230X (ISSN-L)
DOI: 10.1016/b978-0-12-800092-2.00001-0
PMC: PMC4445717
OpenAlex: W2394990651
Cited by: 204
References: 127
Citations by year: 2026: 3 · 2025: 17 · 2024: 14 · 2023: 24 · 2022: 19 · 2021: 20 · 2020: 25 · 2019: 28 · 2018: 14 · 2017: 15 · 2016: 12 · 2015: 12 · 2014: 1
FWCI: 18.61
Type: book chapter
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Advances in cancer research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Lincoln (University of Nebraska) (submittedVersion)
Funders: National Institutes of Health (8p20gm103489-10)
National Cancer Institute (R01CA165574)
National Institute of General Medical Sciences (P20-GM103489)
National Center for Research Resources (P20RR018759)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords: hyaluronidase, hyaluronic acid, metastasis, tumor invasion, hyaluronan oligosaccharides, hyaluronan synthase, substrate specificity, enzyme structure, hyaluronidase inhibitors, tumor imaging, cancer therapy
MeSH terms: Animals, Cell Movement, Fibroblasts, Humans, Hyaluronic Acid, Hyaluronoglucosaminidase, Molecular Conformation, Molecular Weight, Neoplasm Metastasis, Neoplasms, Polymers, Prognosis, Alternative Splicing, Disease Progression, Mole Rats, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Emerging Roles for Hyaluronidase in Cancer Metastasis and Therapy

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks